Please login to the form below

Not currently logged in
Email:
Password:

medicines access

This page shows the latest medicines access news and features for those working in and with pharma, biotech and healthcare.

Sandoz’s biosimilar medicine application accepted by FDA

Sandoz’s biosimilar medicine application accepted by FDA

Recently, the European Medicines Agency (EMA) also accepted the application for Sandoz’s proposed Hyrimoz HCF. ... By committing to bring biosimilar formulations such as Hyrimoz citrate-free HCF to patients, we are serving a critical need in expanding

Latest news

More from news
Approximately 4 fully matching, plus 458 partially matching documents found.

Latest Intelligence

  • A new focus on patient-centricity through remote healthcare A new focus on patient-centricity through remote healthcare

    to deliver ‘at home initiation’ processes for new medicines. ... Another example is enabling patients to have access to medicines at home during lockdown, that would otherwise have been denied, and ensuring that those patients are set up and

  • Solving healthcare problems Solving healthcare problems

    We have seen the rapid development of and access to vaccines and medicines and government-led behavioural change programmes. ... In turn, this has sparked broad debate around the possibilities afforded by rapidly developing medicines and vaccines, the

  • The power of the patient influencer The power of the patient influencer

    They may be advocating for their fellow patients behind the scenes, lobbying NICE for access to medicines, or publicising fundraising efforts via their local media.

  • Piloting a route to the biosimilars opportunities in Europe Piloting a route to the biosimilars opportunities in Europe

    The low risks of interchangeability. Interest in biosimilars is strong, and as understanding grows and trust builds around this alternative route to medicines access, that interest continues to grow. ... In addition, national drug authorities across

  • Avoiding A Series of Unfortunate Events: launch lessons from lockdown Avoiding A Series of Unfortunate Events: launch lessons from lockdown

    Pharma’s track record of launching medicines isn’t quite ‘A Series of Unfortunate Events’, but its performance is variable at best. ... The pressure on healthcare systems is only going to continue – and the impact on drug launches and access to

More from intelligence
Approximately 0 fully matching, plus 105 partially matching documents found.

Latest appointments

  • VMLY&Rx launches new payer agency in the US VMLY&Rx launches new payer agency in the US

    The VMLY&Rx Payer team will aim to provide strategic support to clients in the US working across the product lifecycle, including the delivery of patient-centred, value-focused access and ... They play a huge role in determining whether patients can

  • Pfizer’s Alan Maine moves to Edelman Pfizer’s Alan Maine moves to Edelman

    Maine, who previously served as head of policy and public affairs at Pfizer UK, was responsible for government affairs and market access policy development activity, covering both corporate and therapy area ... During his time at Pfizer, Maine also

  • Sobi names Holly May VP of sales and marketing, US Sobi names Holly May VP of sales and marketing, US

    May’s new role will see her lead the biopharma’s commercial team in bringing Sobi’s medicines to the country. ... She will also collaborate with the operations and patient access team to ensure the medicines are accessible to as many appropriate

  • Inceptua Medicines Access appoints senior new-hires Inceptua Medicines Access appoints senior new-hires

    Multipharma’s new speciality business unit, Inceptua has appointed Ruth Rostron as its new senior project manager, a role that will see her focus on design and implementation of medicines access

  • Sandoz UK promotes Tim de Gavre to country head Sandoz UK promotes Tim de Gavre to country head

    As a company, Sandoz has an exciting portfolio of medicines and future product pipeline. ... I look forward to working with the Sandoz team, and in partnership with the NHS to help patients access these important medicines.”.

More from appointments
Approximately 0 fully matching, plus 20 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 26 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...